{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:40:43Z","timestamp":1790862043511,"version":"4.1.0"},"reference-count":177,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.bcp.2010.07.039","type":"journal-article","created":{"date-parts":[[2010,8,8]],"date-time":"2010-08-08T04:37:25Z","timestamp":1281242245000},"page":"1936-1945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Inflammation and survival pathways: Chronic lymphocytic leukemia as a model system"],"prefix":"10.1016","volume":"80","author":[{"given":"Lisa S.","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumudha","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varsha","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2010.07.039_bib0005","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1182\/asheducation-2004.1.163","article-title":"Chronic lymphocytic leukemia","author":"Byrd","year":"2004","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.bcp.2010.07.039_bib0010","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/1042819021000035756","article-title":"Biological and clinical heterogeneity of B-cell chronic lymphocytic leukemia","volume":"44","author":"D\u2019Arena","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bcp.2010.07.039_bib0015","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1468-0734.2002.00303.x","article-title":"Management of chronic lymphocytic leukemia: a changing field","volume":"6","author":"Keating","year":"2002","journal-title":"Rev Clin Exp Hematol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1182\/asheducation-2003.1.153","article-title":"Biology and treatment of chronic lymphocytic leukemia","author":"Keating","year":"2003","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.bcp.2010.07.039_bib0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/00001622-200001000-00004","article-title":"Update on the biology of chronic lymphocytic leukemia","volume":"12","author":"Bannerji","year":"2000","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0030","first-page":"107","article-title":"Chronic lymphocytic leukemia","volume":"26","author":"Keating","year":"1999","journal-title":"Semin Oncol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0035","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1056\/NEJMra041720","article-title":"Chronic lymphocytic leukemia","volume":"352","author":"Chiorazzi","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2010.07.039_bib0040","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1182\/blood-2002-01-0189","article-title":"Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin","volume":"101","author":"Decker","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0045","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0092-8674(94)90506-1","article-title":"C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2","volume":"76","author":"Hengartner","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0050","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.6093263","article-title":"Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation","volume":"226","author":"Tsujimoto","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.bcp.2010.07.039_bib0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0092-8674(89)90174-8","article-title":"bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation","volume":"57","author":"McDonnell","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0060","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0092-8674(93)90508-N","article-title":"bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death","volume":"74","author":"Boise","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0065","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1074\/jbc.C000871200","article-title":"Bcl-B, a novel Bcl-2 family member that differentially binds and regulates Bax and Bak","volume":"276","author":"Ke","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.07.039_bib0070","first-page":"665","article-title":"bcl-w, a novel member of the bcl-2 family, promotes cell survival","volume":"13","author":"Gibson","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2010.07.039_bib0075","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1073\/pnas.90.8.3516","article-title":"MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2","volume":"90","author":"Kozopas","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.07.039_bib0080","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.4049\/jimmunol.151.4.1979","article-title":"Characterization of A1, a novel hemopoietic-specific early-response gene with sequence similarity to bcl-2","volume":"151","author":"Lin","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0085","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2007-09-078162","article-title":"Bcl-2-family proteins and hematologic malignancies: history and future prospects","volume":"111","author":"Reed","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0090","first-page":"1309","article-title":"Immunohistochemical analysis of Mcl-1 protein in human tissues. Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo","volume":"146","author":"Krajewski","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0095","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1046\/j.1365-2141.1996.d01-1856.x","article-title":"In leukaemic CD5+ B cells the expression of BCL-2 gene family is shifted toward protection from apoptosis","volume":"94","author":"Gottardi","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0100","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature02067","article-title":"Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1","volume":"426","author":"Opferman","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.07.039_bib0105","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1182\/blood.V88.8.3109.bloodjournal8883109","article-title":"Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia","volume":"88","author":"Bullrich","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0110","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1056\/NEJMoa050995","article-title":"A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia","volume":"353","author":"Calin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bcp.2010.07.039_bib0115","doi-asserted-by":"crossref","first-page":"13944","DOI":"10.1073\/pnas.0506654102","article-title":"miR-15 and miR-16 induce apoptosis by targeting BCL2","volume":"102","author":"Cimmino","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.07.039_bib0120","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1126\/science.7878471","article-title":"Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice","volume":"267","author":"Motoyama","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bcp.2010.07.039_bib0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(93)80065-M","article-title":"Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair","volume":"75","author":"Veis","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0130","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/blood.V91.9.3379","article-title":"Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses","volume":"91","author":"Kitada","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0135","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1182\/blood.V91.3.991","article-title":"Elevated expression of the apoptotic regulator Mcl-1 at the time of leukemic relapse","volume":"91","author":"Kaufmann","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V100.1.194","article-title":"Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells","volume":"100","author":"Derenne","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0145","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.1182\/blood-2004-05-1699","article-title":"Cell death of bioenergetically compromised and transcriptionally challenged CLL lymphocytes by chlorinated ATP","volume":"105","author":"Balakrishnan","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0150","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1158\/1078-0432.CCR-05-0553","article-title":"Mechanisms of cell death of chronic lymphocytic leukemia lymphocytes by RNA-directed agent, 8-NH2-adenosine","volume":"11","author":"Balakrishnan","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2010.07.039_bib0155","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood-2009-03-212852","article-title":"Pim kinase inhibitor, SGI-1776, induces apoptosis in chronic lymphocytic leukemia cells","volume":"114","author":"Chen","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0160","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1182\/blood-2005-04-1678","article-title":"Transcription inhibition by flavopiridol: mechanism of chronic lymphocytic leukemia cell death","volume":"106","author":"Chen","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0165","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cancergencyto.2004.08.012","article-title":"The value of fluorescence in situ hybridization in the diagnosis and prognosis of chronic lymphocytic leukemia","volume":"158","author":"Glassman","year":"2005","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.bcp.2010.07.039_bib0170","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/blood.V96.2.393","article-title":"Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate antiapoptosis proteins in B-cell chronic lymphocytic leukemia","volume":"96","author":"Kitada","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0175","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1200\/JCO.2006.07.1191","article-title":"Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia","volume":"25","author":"O\u2019Brien","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0180","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1182\/blood.V99.3.1038","article-title":"The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction","volume":"99","author":"Byrd","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0890","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1182\/blood-2009-10-246199","article-title":"Influence of bone marrow stromal microenvironment on forodesine-induced response in CLL primary cells","volume":"116","author":"Balakrishnan","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0190","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Burger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0195","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1158\/0008-5472.CAN-08-0579","article-title":"Down-regulation of myeloid cell leukemia-1 through inhibiting Erk\/Pin 1 pathway by sorafenib facilitates chemosensitization in breast cancer","volume":"68","author":"Ding","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.07.039_bib0200","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1182\/blood-2008-07-170241","article-title":"Mcl-1: the 1 in CLL","volume":"112","author":"Gandhi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0205","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2009-09-242719","article-title":"Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression","volume":"115","author":"Ghosh","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0210","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2009-07-233718","article-title":"Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance","volume":"114","author":"Kurtova","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0215","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood.V100.5.1795.h81702001795_1795_1801","article-title":"Protection of CLL B cells by a follicular dendritic cell line is dependent on induction of Mcl-1","volume":"100","author":"Pedersen","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0220","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1182\/blood-2009-03-212837","article-title":"B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406","volume":"114","author":"Quiroga","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0225","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V99.3.1030","article-title":"Distinctive features of \u201cnurselike\u201d cells that differentiate in the context of chronic lymphocytic leukemia","volume":"99","author":"Tsukada","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0230","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1182\/blood-2008-05-157131","article-title":"Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers","volume":"112","author":"Pepper","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0235","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2141.1996.00305.x","article-title":"Human bone marrow stromal cells prevent apoptosis and support the survival of chronic lymphocytic leukaemia cells in vitro","volume":"92","author":"Panayiotidis","year":"1996","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0240","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1046\/j.1365-2141.2003.04679.x","article-title":"Role of the microenvironment in chronic lymphocytic leukaemia","volume":"123","author":"Caligaris-Cappio","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0245","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/84219","article-title":"Lymphocyte traffic control by chemokines","volume":"2","author":"Moser","year":"2001","journal-title":"Nat Immunol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0250","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jlb.65.1.6","article-title":"Chemokines: signal lamps for trafficking of T and B cells for development and effector function","volume":"65","author":"Kim","year":"1999","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0255","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.184.3.1101","article-title":"A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)","volume":"184","author":"Bleul","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2010.07.039_bib0260","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1073\/pnas.91.6.2305","article-title":"Molecular cloning and structure of a pre-B-cell growth-stimulating factor","volume":"91","author":"Nagasawa","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.07.039_bib0265","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-2776(08)60910-4","article-title":"Chemokines and their receptors in lymphocyte traffic and HIV infection","volume":"74","author":"Loetscher","year":"2000","journal-title":"Adv Immunol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0270","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1359-6101(02)00045-X","article-title":"Macrophage inflammatory protein-1","volume":"13","author":"Menten","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bcp.2010.07.039_bib0275","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1182\/blood-2003-03-0989","article-title":"CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells","volume":"102","author":"Deaglio","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0280","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1158\/0008-5472.CAN-08-4173","article-title":"CD38\/CD31, the CCL3 and CCL4 chemokines, and CD49d\/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival","volume":"69","author":"Zucchetto","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.07.039_bib0285","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1182\/blood-2004-10-3873","article-title":"CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival","volume":"105","author":"Deaglio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0290","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V94.11.3658","article-title":"Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells","volume":"94","author":"Burger","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0295","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1038\/sj.leu.2401602","article-title":"Overexpression of the chemokine receptor CXCR4 in B cell chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1)","volume":"13","author":"Mohle","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.07.039_bib0300","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1074-7613(00)80165-X","article-title":"Chemokines: a new classification system and their role in immunity","volume":"12","author":"Zlotnik","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2010.07.039_bib0305","first-page":"143","article-title":"Anti-apoptosis function of TNF-alpha in chronic lymphocytic leukemia: lessons from Crohn's disease and the therapeutic potential of bupropion to lower TNF-alpha","volume":"53","author":"Kast","year":"2005","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"10.1016\/j.bcp.2010.07.039_bib0310","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3109\/10428199409051650","article-title":"TNF receptors in chronic lymphocytic leukemia","volume":"13","author":"Waage","year":"1994","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bcp.2010.07.039_bib0315","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","article-title":"Interleukin-10: new perspectives on an old cytokine","volume":"226","author":"Mosser","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.bcp.2010.07.039_bib0320","doi-asserted-by":"crossref","first-page":"6735","DOI":"10.1158\/1078-0432.CCR-07-4843","article-title":"The interleukin-8 pathway in cancer","volume":"14","author":"Waugh","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bcp.2010.07.039_bib0325","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bcp.2010.07.039_bib0330","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cyto.2009.12.001","article-title":"IL-7 receptor is expressed on adult pre-B-cell acute lymphoblastic leukemia and other B-cell derived neoplasms and correlates with expression of proliferation and survival markers","volume":"50","author":"Sasson","year":"2010","journal-title":"Cytokine"},{"key":"10.1016\/j.bcp.2010.07.039_bib0335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4161\/mabs.2.1.10561","article-title":"Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia","volume":"2","author":"Gowda","year":"2010","journal-title":"MAbs"},{"key":"10.1016\/j.bcp.2010.07.039_bib0340","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/cncr.10772","article-title":"Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia","volume":"95","author":"Lai","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2010.07.039_bib0345","doi-asserted-by":"crossref","first-page":"15524","DOI":"10.1073\/pnas.242606799","article-title":"Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia","volume":"99","author":"Calin","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.07.039_bib0350","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood-2007-03-081133","article-title":"Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer","volume":"110","author":"Loffler","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0355","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.4049\/jimmunol.179.8.5082","article-title":"Modulation of miR-155 and miR-125b levels following lipopolysaccharide\/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock","volume":"179","author":"Tili","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0360","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1073\/pnas.0602266103","article-title":"Pre-B cell proliferation and lymphoblastic leukemia\/high-grade lymphoma in E(mu)-miR155 transgenic mice","volume":"103","author":"Costinean","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.07.039_bib0365","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2141.2008.07152.x","article-title":"MYC translocation in chronic lymphocytic leukaemia is associated with increased prolymphocytes and a poor prognosis","volume":"142","author":"Huh","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0370","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1182\/blood-2009-10-230060","article-title":"STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cells","volume":"115","author":"Hazan-Halevy","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0375","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.leu.2403398","article-title":"A sustained activation of PI3K\/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells","volume":"18","author":"Cuni","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.07.039_bib0380","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.4049\/jimmunol.164.4.2200","article-title":"Modulation of NF-kappa B activity and apoptosis in chronic lymphocytic leukemia B cells","volume":"164","author":"Furman","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0385","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s10495-009-0315-0","article-title":"NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy","volume":"14","author":"Shen","year":"2009","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2010.07.039_bib0390","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ccr.2007.07.003","article-title":"Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma","volume":"12","author":"Keats","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0395","doi-asserted-by":"crossref","first-page":"21631","DOI":"10.1074\/jbc.M300609200","article-title":"NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4","volume":"278","author":"Helbig","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.07.039_bib0400","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1677\/erc.0.0060021","article-title":"Survival signals within the tumour microenvironment suppress drug-induced apoptosis: lessons learned from B lymphomas","volume":"6","author":"Taylor","year":"1999","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.bcp.2010.07.039_bib0405","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2006-06-027755","article-title":"BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway","volume":"109","author":"Endo","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0410","doi-asserted-by":"crossref","first-page":"19643","DOI":"10.1073\/pnas.0810965105","article-title":"Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL","volume":"105","author":"Pekarsky","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.07.039_bib0415","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1042\/BST0350288","article-title":"Modulation of granulocyte apoptosis can influence the resolution of inflammation","volume":"35","author":"Rossi","year":"2007","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.bcp.2010.07.039_bib0420","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/09629359990595","article-title":"Expression of Bcl-2 in inflammatory sites from patients with active Behcet's disease","volume":"8","author":"Hamzaoui","year":"1999","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.bcp.2010.07.039_bib0425","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2353\/ajpath.2006.050058","article-title":"The involvement of the apoptosis-modulating proteins ERK 1\/2, Bcl-xL and Bax in the resolution of acute inflammation in vivo","volume":"168","author":"Sawatzky","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0430","doi-asserted-by":"crossref","first-page":"26865","DOI":"10.1016\/S0021-9258(18)47099-8","article-title":"Interleukin-3 and bryostatin-1 mediate hyperphosphorylation of BCL2 alpha in association with suppression of apoptosis","volume":"269","author":"May","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.07.039_bib0435","doi-asserted-by":"crossref","first-page":"11671","DOI":"10.1074\/jbc.272.18.11671","article-title":"Bcl-2 phosphorylation required for anti-apoptosis function","volume":"272","author":"Ito","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.07.039_bib0440","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.leu.2402090","article-title":"Phosphorylation of Bcl2 and regulation of apoptosis","volume":"15","author":"Ruvolo","year":"2001","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.07.039_bib0445","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/leu.2008.175","article-title":"BCL-2 phosphorylation modulates sensitivity to the BH3 mimetic GX15-070 (Obatoclax) and reduces its synergistic interaction with bortezomib in chronic lymphocytic leukemia cells","volume":"22","author":"Perez-Galan","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.07.039_bib0450","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/sj.leu.2404248","article-title":"Bcl2 phosphorylation and active PKC alpha are associated with poor survival in AML","volume":"20","author":"Kurinna","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.bcp.2010.07.039_bib0455","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.emboj.7600104","article-title":"Phosphorylation of BCL-2 regulates ER Ca2+ homeostasis and apoptosis","volume":"23","author":"Bassik","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2010.07.039_bib0460","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1128\/MCB.20.5.1886-1896.2000","article-title":"Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway","volume":"20","author":"Breitschopf","year":"2000","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0465","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1084\/jem.189.11.1815","article-title":"Dephosphorylation targets Bcl-2 for ubiquitin-dependent degradation: a link between the apoptosome and the proteasome pathway","volume":"189","author":"Dimmeler","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2010.07.039_bib0470","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0968-0004(00)89102-1","article-title":"AU-rich elements: characterization and importance in mRNA degradation","volume":"20","author":"Chen","year":"1995","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.bcp.2010.07.039_bib0475","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1128\/MCB.15.10.5777","article-title":"mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation","volume":"15","author":"Chen","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0480","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1038\/sj.onc.1208069","article-title":"Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis","volume":"23","author":"Herrant","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2010.07.039_bib0485","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1128\/MCB.18.8.4883","article-title":"mcl-1 is an immediate-early gene activated by the granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling pathway and is one component of the GM-CSF viability response","volume":"18","author":"Chao","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0490","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1038\/sj.onc.1206423","article-title":"A major role for Mcl-1 antiapoptotic protein in the IL-6-induced survival of human myeloma cells","volume":"22","author":"Jourdan","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2010.07.039_bib0495","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1128\/MCB.19.9.6195","article-title":"The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase\/Akt signaling pathway through a transcription factor complex containing CREB","volume":"19","author":"Wang","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0500","doi-asserted-by":"crossref","first-page":"21688","DOI":"10.1074\/jbc.M000915200","article-title":"Myeloid cell leukemia 1 is phosphorylated through two distinct pathways, one associated with extracellular signal-regulated kinase activation and the other with G2\/M accumulation or protein phosphatase 1\/2A inhibition","volume":"275","author":"Domina","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.07.039_bib0505","doi-asserted-by":"crossref","first-page":"43730","DOI":"10.1074\/jbc.M207951200","article-title":"Phosphorylation and inactivation of myeloid cell leukemia 1 by JNK in response to oxidative stress","volume":"277","author":"Inoshita","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.07.039_bib0510","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1038\/sj.onc.1207692","article-title":"MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol","volume":"23","author":"Domina","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2010.07.039_bib0515","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.molcel.2006.02.009","article-title":"Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1","volume":"21","author":"Maurer","year":"2006","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0520","doi-asserted-by":"crossref","first-page":"18407","DOI":"10.1074\/jbc.M610010200","article-title":"Serine 64 phosphorylation enhances the antiapoptotic function of Mcl-1","volume":"282","author":"Kobayashi","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.07.039_bib0525","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3324\/haematol.12098","article-title":"Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12\/CXCR4 axis and the NF-kappaB and JNK\/AP-1 pathways","volume":"93","author":"Scupoli","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.bcp.2010.07.039_bib0530","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.cell.2005.06.009","article-title":"Mule\/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis","volume":"121","author":"Zhong","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0535","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature08646","article-title":"Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival","volume":"463","author":"Schwickart","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.07.039_bib0540","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/j.1460-2075.1994.tb06307.x","article-title":"Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes","volume":"13","author":"Merino","year":"1994","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2010.07.039_bib0545","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1021\/jm030190z","article-title":"Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte\/leukemia-2 proteins","volume":"46","author":"Kitada","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2010.07.039_bib0550","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.cdd.4401937","article-title":"Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins","volume":"13","author":"Zhai","year":"2006","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.bcp.2010.07.039_bib0555","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1182\/blood-2006-10-047951","article-title":"Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma","volume":"109","author":"Trudel","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0560","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1158\/0008-5472.CAN-07-1919","article-title":"Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax)","volume":"68","author":"Konopleva","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.07.039_bib0565","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2006-07-034173","article-title":"The BH3-mimetic GX15-070 synergizes with bortezomib in mantle cell lymphoma by enhancing Noxa-mediated activation of Bak","volume":"109","author":"Perez-Galan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0570","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/1535-7163.MCT-08-0285","article-title":"BH3-only protein mimetic obatoclax sensitizes cholangiocarcinoma cells to Apo2L\/TRAIL-induced apoptosis","volume":"7","author":"Mott","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2010.07.039_bib0575","doi-asserted-by":"crossref","first-page":"19512","DOI":"10.1073\/pnas.0709443104","article-title":"Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis","volume":"104","author":"Nguyen","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.07.039_bib0580","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1182\/blood-2008-02-137943","article-title":"Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia","volume":"113","author":"O\u2019Brien","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0585","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2007-12-126946","article-title":"Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells","volume":"112","author":"Balakrishnan","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0590","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF00685601","article-title":"A preliminary clinical study of gossypol in advanced human cancer","volume":"30","author":"Stein","year":"1992","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0595","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1010686204736","article-title":"Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I\/II clinical trial","volume":"66","author":"Van Poznak","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.bcp.2010.07.039_bib0600","doi-asserted-by":"crossref","first-page":"595a","DOI":"10.1182\/blood.V108.11.2100.2100","article-title":"AT-101, a pan-inhibitor of Bcl-2 family anti-apoptotic proteins, antagonizes the protective effect conferred by nurse-like cells on primary chronic lymphocytic leukemia cells","volume":"108","author":"James","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0605","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood-2008-02-138560","article-title":"AT-101 induces apoptosis in CLL B cells and overcomes stromal cell-mediated Mcl-1 induction and drug resistance","volume":"113","author":"Balakrishnan","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0610","doi-asserted-by":"crossref","first-page":"835a","DOI":"10.1182\/blood.V106.11.2979.2979","article-title":"AT 101, an inhibitor of Bcl-2 family members, is cytotoxic to a heterogeneous group of primary CLL samples and synergistic with rituximab","volume":"106","author":"James","year":"2005","journal-title":"Blood"},{"issue":"Suppl.","key":"10.1016\/j.bcp.2010.07.039_bib0615","first-page":"220","article-title":"Phase I trial of AT-101, an orally bioavailable inhibitor of Bcl-2, in patients with advanced malignancies","volume":"3","author":"Saleh","year":"2005","journal-title":"AACR-NCI-EORTC Int Conf"},{"key":"10.1016\/j.bcp.2010.07.039_bib0620","doi-asserted-by":"crossref","first-page":"803a","DOI":"10.1182\/blood.V108.11.2838.2838","article-title":"A phase II, open label study of AT-101 in combination with rituximab in patients with relapsed or refractory chronic lymphocytic leukemia","volume":"108","author":"Castro","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0625","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2004.12.030","article-title":"Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function","volume":"17","author":"Chen","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0630","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2010.07.039_bib0635","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ccr.2006.08.027","article-title":"The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak\/Bax if Mcl-1 is neutralized","volume":"10","author":"van Delft","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0640","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.ccr.2006.10.006","article-title":"Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia","volume":"10","author":"Konopleva","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0645","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1172\/JCI28281","article-title":"Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737","volume":"117","author":"Del Gaizo Moore","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2010.07.039_bib0650","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1182\/blood-2007-06-098012","article-title":"BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia","volume":"111","author":"Del Gaizo Moore","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0655","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1128\/MCB.01481-08","article-title":"Bim up-regulation by histone deacetylase inhibitors mediates interactions with the Bcl-2 antagonist ABT-737: evidence for distinct roles for Bcl-2, Bcl-xL and Mcl-1","volume":"29","author":"Chen","year":"2009","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0660","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0092-8674(84)90309-X","article-title":"Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region","volume":"37","author":"Cuypers","year":"1984","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0665","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1172\/JCI26273","article-title":"The survival kinases Akt and Pim as potential pharmacological targets","volume":"115","author":"Amaravadi","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bcp.2010.07.039_bib0670","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1016\/j.ejca.2008.06.044","article-title":"Potential roles for the PIM1 kinase in human cancer\u2014a molecular and therapeutic appraisal","volume":"44","author":"Shah","year":"2008","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.bcp.2010.07.039_bib0675","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1101\/gad.1105003","article-title":"The serine\/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor","volume":"17","author":"Fox","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.bcp.2010.07.039_bib0680","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1002\/j.1460-2075.1995.tb07251.x","article-title":"Proviral tagging in E mu-myc transgenic mice lacking the Pim-1 proto-oncogene leads to compensatory activation of Pim-2","volume":"14","author":"van der Lugt","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2010.07.039_bib0685","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1093\/emboj\/18.12.3359","article-title":"Pim kinase expression is induced by LTP stimulation and required for the consolidation of enduring LTP","volume":"18","author":"Konietzko","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.bcp.2010.07.039_bib0690","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/scbi.1996.0038","article-title":"Complementation tagging of cooperating oncogenes in knockout mice","volume":"7","author":"Allen","year":"1996","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2121-7-1","article-title":"Pim kinases phosphorylate multiple sites on Bad and promote 14-3-3 binding and dissociation from Bcl-XL","volume":"7","author":"Macdonald","year":"2006","journal-title":"BMC Cell Biol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0700","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1074\/jbc.M409123200","article-title":"Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase","volume":"280","author":"Qian","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.07.039_bib0705","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/1541-7786.MCR-04-0192","article-title":"Pim-1 kinase stability is regulated by heat shock proteins and the ubiquitin-proteasome pathway","volume":"3","author":"Shay","year":"2005","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bcp.2010.07.039_bib0710","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/ncb1618","article-title":"PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation","volume":"9","author":"Zippo","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0715","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1038\/onc.2008.123","article-title":"Pim kinase-dependent inhibition of c-Myc degradation","volume":"27","author":"Zhang","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2010.07.039_bib0720","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ncponc0558","article-title":"Mechanisms of disease: oncogene addiction\u2014a rationale for molecular targeting in cancer therapy","volume":"3","author":"Weinstein","year":"2006","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0725","first-page":"293","article-title":"Collaboration of pim-1 and bcl-2 in lymphomagenesis","volume":"182","author":"Acton","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0730","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V99.12.4531","article-title":"Complementary functions of the antiapoptotic protein A1 and serine\/threonine kinase pim-1 in the BCR\/ABL-mediated leukemogenesis","volume":"99","author":"Nieborowska-Skorska","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0735","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1158\/0008-5472.CAN-05-4272","article-title":"Pim-3, a proto-oncogene with serine\/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines","volume":"66","author":"Li","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.07.039_bib0740","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.febslet.2004.06.050","article-title":"Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site","volume":"571","author":"Aho","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bcp.2010.07.039_bib0745","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S1097-2765(05)00012-2","article-title":"14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation","volume":"6","author":"Datta","year":"2000","journal-title":"Mol Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0750","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0092-8674(00)81382-3","article-title":"Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)","volume":"87","author":"Zha","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2010.07.039_bib0755","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1158\/1541-7786.MCR-06-0388","article-title":"Pim-1 kinase-dependent phosphorylation of p21Cip1\/WAF1 regulates its stability and cellular localization in H1299 cells","volume":"5","author":"Zhang","year":"2007","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.bcp.2010.07.039_bib0760","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1158\/0008-5472.CAN-08-0634","article-title":"Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels","volume":"68","author":"Morishita","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.07.039_bib0765","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.biocel.2005.10.010","article-title":"The oncogenic serine\/threonine kinase Pim-1 directly phosphorylates and activates the G2\/M specific phosphatase Cdc25C","volume":"38","author":"Bachmann","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0770","doi-asserted-by":"crossref","first-page":"18659","DOI":"10.1074\/jbc.274.26.18659","article-title":"Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway","volume":"274","author":"Mochizuki","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bcp.2010.07.039_bib0775","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jss.2008.03.033","article-title":"Serine\/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell","volume":"153","author":"Gong","year":"2009","journal-title":"J Surg Res"},{"key":"10.1016\/j.bcp.2010.07.039_bib0780","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1182\/blood-2008-10-184515","article-title":"Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia","volume":"114","author":"Tamburini","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0785","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/MCB.22.8.2853-2861.2002","article-title":"Translational control of cell fate: availability of phosphorylation sites on translational repressor 4E-BP1 governs its proapoptotic potency","volume":"22","author":"Li","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0790","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1182\/blood-2003-09-3126","article-title":"Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3","volume":"103","author":"Peltola","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0795","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1073\/pnas.042035699","article-title":"Pim serine\/threonine kinases regulate the stability of Socs-1 protein","volume":"99","author":"Chen","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bcp.2010.07.039_bib0800","doi-asserted-by":"crossref","first-page":"5145","DOI":"10.1038\/sj.onc.1210323","article-title":"Negative regulation of Pim-1 protein kinase levels by the B56beta subunit of PP2A","volume":"26","author":"Ma","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2010.07.039_bib0805","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1006\/bbrc.2001.4405","article-title":"Regulation of Pim-1 by Hsp90","volume":"281","author":"Mizuno","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.bcp.2010.07.039_bib0810","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1038\/onc.2009.124","article-title":"Pim-1 plays a pivotal role in hypoxia-induced chemoresistance","volume":"28","author":"Chen","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2010.07.039_bib0815","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2353\/ajpath.2009.080972","article-title":"Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation","volume":"175","author":"Chen","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0820","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4142\/jvs.2001.2.3.167","article-title":"Pim-1: a serine\/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis","volume":"2","author":"Wang","year":"2001","journal-title":"J Vet Sci"},{"key":"10.1016\/j.bcp.2010.07.039_bib0825","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1247\/csf.26.95","article-title":"Stromal cells provide signals different from cytokines for STAT5 activation in hematopoietic cells","volume":"26","author":"Sato","year":"2001","journal-title":"Cell Struct Funct"},{"key":"10.1016\/j.bcp.2010.07.039_bib0830","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2567.2006.02382.x","article-title":"Interleukin-5 regulates genes involved in B-cell terminal maturation","volume":"118","author":"Horikawa","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2010.07.039_bib0835","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1080\/10428190310001641251","article-title":"Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma","volume":"45","author":"Cohen","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.bcp.2010.07.039_bib0840","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1084\/jem.20082074","article-title":"Dissection of PIM serine\/threonine kinases in FLT3-ITD-induced leukemogenesis reveals PIM1 as regulator of CXCL12-CXCR4-mediated homing and migration","volume":"206","author":"Grundler","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.bcp.2010.07.039_bib0845","doi-asserted-by":"crossref","first-page":"6409","DOI":"10.4049\/jimmunol.173.10.6409","article-title":"IL-5 and granulocyte-macrophage colony-stimulating factor activate STAT3 and STAT5 and promote Pim-1 and cyclin D3 protein expression in human eosinophils","volume":"173","author":"Stout","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0850","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/icb.2010.1","article-title":"New paradigms in basophil development, regulation and function","volume":"88","author":"Siracusa","year":"2010","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.bcp.2010.07.039_bib0855","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1182\/blood-2008-04-149419","article-title":"IL-3 induces a Pim1-dependent antiapoptotic pathway in primary human basophils","volume":"112","author":"Didichenko","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2010.07.039_bib0860","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1365-2567.2002.01517.x","article-title":"Interleukin-3, but not granulocyte-macrophage colony-stimulating factor and interleukin-5, inhibits apoptosis of human basophils through phosphatidylinositol 3-kinase: requirement of NF-kappaB-dependent and -independent pathways","volume":"107","author":"Zheng","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.bcp.2010.07.039_bib0865","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1158\/1535-7163.MCT-08-1037","article-title":"Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells","volume":"8","author":"Beharry","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.bcp.2010.07.039_bib0870","doi-asserted-by":"crossref","first-page":"6916","DOI":"10.1158\/0008-5472.CAN-07-0320","article-title":"Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity","volume":"67","author":"Pogacic","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.bcp.2010.07.039_bib0875","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/jm800937p","article-title":"Synthesis and evaluation of novel inhibitors of Pim-1 and Pim-2 protein kinases","volume":"52","author":"Xia","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bcp.2010.07.039_bib0880","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1517\/13543770903496442","article-title":"Pim kinase inhibitors: a survey of the patent literature","volume":"20","author":"Morwick","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bcp.2010.07.039_bib0885","first-page":"362","article-title":"PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis","volume":"119","author":"Hu","year":"2009","journal-title":"J Clin Invest"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210005770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295210005770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:57:59Z","timestamp":1757768279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295210005770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":177,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0006295210005770"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2010.07.039","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation and survival pathways: Chronic lymphocytic leukemia as a model system","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2010.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}